|
| Press Releases |
|
 |
|
| Friday, March 13, 2026 |
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo |
| more info >> |
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo |
| On 12 March 2026, China Medical System Holdings Limited is pleased to announce that its subsidiary, Dermavon Holdings Limited has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix(R)) (the "Product", marketed as Opzelura(R) in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. more info >> |
|
| Thursday, March 5, 2026 |
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity |
| more info >> |
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection ("CMS-D008") received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration ("NMPA") on 4 March 2026. more info >> |
|
| Tuesday, February 24, 2026 |
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China |
| more info >> |
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China |
| CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China more info >> |
|
| Friday, January 30, 2026 |
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China |
| CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China more info >> |
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China |
| CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China more info >> |
|
| Wednesday, July 16, 2025 |
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
| more info >> |
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
| On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
International Healthcare Week opens today, fuelling healthcare breakthroughs
May 11, 2026 22:48 HKT/SGT
|
|
|
Smart Ways to Organise Payments for Better Rewards and Everyday Savings
May 11, 2026 22:46 HKT/SGT
|
|
|
International Healthcare Week opens today, fuelling healthcare breakthroughs
May 11, 2026 20:48: JST
|
|
|
GMG's THERMAL-XR to Be Applied on up to 600 Air Conditioners for Two Luxury Towers in Australia
May 11, 2026 20:29 HKT/SGT
|
|
|
スパークス・グループ、「未来創生4号ファンド」設立
May 11, 2026 16:00: JST
|
|
|
トヨタ、インド・マハラシュトラ州に新工場を建設
May 11, 2026 16:00: JST
|
|
|
Honda、「N-BOX」シリーズが累計販売台数300万台を突破
May 11, 2026 16:00: JST
|
|
|
國泰君安國際旗下兩隻貨幣基金獲聯合國際確認維持「AAAmf」評級
May 11, 2026 15:16 HKT/SGT
|
|
|
国泰君安国际旗下两只货币基金获联合国际确认维持"AAAmf"评级
May 11, 2026 15:16 HKT/SGT
|
|
|
國泰君安國際保薦樂動機器人登陸港交所主板
May 11, 2026 14:39 HKT/SGT
|
|
|
国泰君安国际保荐乐动机器人登陆港交所主板
May 11, 2026 14:39 HKT/SGT
|
|
|
三菱重工、次世代宇宙用MPUを活用したオンボードAI物体検知機「AIRIS」が軌道上で船舶検知に成功
May 11, 2026 11:30: JST
|
|
|
TruMerit與Credivera為全球醫療保健專業人員頒發首批可驗證數位憑證
May 8, 2026 23:00 HKT/SGT
|
|
|
TruMerit与Credivera为全球医疗保健专业人员颁发首批可验证数字证书
May 8, 2026 23:00 HKT/SGT
|
|
|
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
May 8, 2026 23:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
